My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 320

    1.

    Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.

    Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL.

    Diabetes. 2007 Aug;56(8):2103-9. Epub 2007 Apr 24.PMID: 17456848 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

    Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL.

    Nat Med. 2006 Jun;12(6):627-35. Epub 2006 May 21.PMID: 16715091 [PubMed - indexed for MEDLINE]Related articles

    3.

    CD3 antibody treatment stimulates the functional capability of regulatory T cells.

    Chatenoud L.

    Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.PMID: 14609225 [PubMed - indexed for MEDLINE]Related articles

    4.

    Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.

    Ploix C, Bergerot I, Fabien N, Perche S, Moulin V, Thivolet C.

    Diabetes. 1998 Jan;47(1):39-44.PMID: 9421372 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.

    Baumann EE, Buckingham F, Herold KC.

    Diabetes. 1995 Aug;44(8):871-7.PMID: 7621990 [PubMed - indexed for MEDLINE]Related articles

    6.

    Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.

    Wu HY, Quintana FJ, Weiner HL.

    J Immunol. 2008 Nov 1;181(9):6038-50.PMID: 18941193 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

    Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.PMID: 17389382 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity.

    Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso A, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL.

    J Neurol Sci. 2008 Nov 15;274(1-2):9-12. Epub 2008 Sep 18. Review.PMID: 18804221 [PubMed - indexed for MEDLINE]Related articles

    9.

    Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.

    Yang W, Hussain S, Mi QS, Santamaria P, Delovitch TL.

    J Immunol. 2004 Oct 1;173(7):4407-16.PMID: 15383571 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

    Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

    Diabetes. 1999 Nov;48(11):2150-6.PMID: 10535448 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    12.

    Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

    Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC.

    Endocrinology. 2007 Nov;148(11):5136-44. Epub 2007 Aug 2.PMID: 17673522 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes.

    Bisikirska BC, Herold KC.

    Ann N Y Acad Sci. 2004 Dec;1037:1-9. Review.PMID: 15699486 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.

    von Herrath MG, Coon B, Wolfe T, Chatenoud L.

    J Immunol. 2002 Jan 15;168(2):933-41.PMID: 11777992 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.

    Belghith M, Bluestone JA, Barriot S, Mégret J, Bach JF, Chatenoud L.

    Nat Med. 2003 Sep;9(9):1202-8. Epub 2003 Aug 24.PMID: 12937416 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.

    Vallera DA, Carroll SF, Brief S, Blazar BR.

    Diabetes. 1992 Apr;41(4):457-64.PMID: 1376702 [PubMed - indexed for MEDLINE]Related articles

    17.

    Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells.

    Wu HY, Center EM, Tsokos GC, Weiner HL.

    Lupus. 2009 Jun;18(7):586-96.PMID: 19433458 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice.

    Johnson GG, Mikulowska A, Butcher EC, McEvoy LM, Michie SA.

    J Immunol. 1999 Nov 15;163(10):5678-85.PMID: 10553098 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.

    Li J, Davis J, Bracht M, Carton J, Armstrong J, Gao W, Scallon B, Fung R, Emmell E, Zimmerman M, Griswold DE, Li L.

    Int Immunopharmacol. 2006 Jun;6(6):880-91. Epub 2006 Jan 27.PMID: 16644473 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis.

    Kohm AP, Williams JS, Bickford AL, McMahon JS, Chatenoud L, Bach JF, Bluestone JA, Miller SD.

    J Immunol. 2005 Apr 15;174(8):4525-34.PMID: 15814673 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity